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IL-8-alpha (TNF)-induced inﬂammatory response in human lung microvascular
endothelial cells (MVECs) is an early event in acute lung injury. Studies have shown that p38mitogen-activated
protein kinase (MAPK), MAPK-activated protein kinase 2 (MK2) and heat shock protein 27 (HSP27) are involved
in the expression of pro-inﬂammatory mediators in other cell types. However, their role in the TNF-induced
inﬂammatory response in lung MVECs has not been determined. We evaluated the role of p38 MAPK, MK2 and
HSP27 in regulating the TNF-induced expression of ICAM-1 and IL-8 in human lung MVECs. Inhibition of p38
MAPK reduced ICAM-1 and IL-8 expression without inﬂuencing NF-κB activation or ICAM-1 and IL-8 mRNA
levels. TNF stimulation induced p38 MAPK-dependent phosphorylation of MK2 and HSP27. MK2 silencing
reduced ICAM-1 and IL-8 expression without inﬂuencing NF-κB activation or ICAM-1 and IL-8 mRNA levels.
HSP27 silencing reduced cellularHSP27 levels andHSP27phosphorylation following TNF stimulationbut hadno
effect on ICAM-1 and IL-8 expression. Our study demonstrates for the ﬁrst time that MK2 mediates post-
transcriptional regulation by p38 MAPK of the TNF-induced expression of ICAM-1 and IL-8 in human lung
MVECs, and that this regulation by the p38 MAPK/MK2 pathway is dissociated from HSP27 phosphorylation.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
One of the earliest events in the pathophysiologyof acute lung injury
and itsmore severe form, acute respiratory distress syndrome (ARDS), is
an increase in circulating levels of pro-inﬂammatory cytokines,
particularly tumornecrosis factor-α (TNF) [1,2]. CirculatingTNF interacts
with lung microvascular endothelial cells to induce the expression of
chemokines and adhesion molecules, including IL-8 and ICAM-1 [3].
Both IL-8 and ICAM-1 are necessary for neutrophil accumulation and
inﬁltration in the lung during acute lung injury and ARDS [1,2,4,5].
Although it iswell known that TNF induces the expressionof ICAM-1
and IL-8 in endothelial cells [3], the mechanisms involved are not fully
understood. Several studies on human umbilical vein endothelial cells
(HUVECs) found that inhibition of the p38 mitogen-activated protein
kinase (MAPK) pathway reduces TNF-stimulated expression of IL-8
without inﬂuencing ICAM-1expression [6,7]. However, howendothelial
cells in other vascular beds utilize the p38 MAPK pathway in the
inﬂammatory response to TNF is unclear, and the role of the p38 MAPKC-320, University of Colorado
: +1 303 315 0963.
g).
l rights reserved.pathway in ICAM-1 and IL-8 expression in human lung microvascular
endothelial cells (MVECs) remains to be determined.
The transcription factor NF-κB plays a major role in controlling the
TNF-induced expression of ICAM-1, IL-8 and other pro-inﬂammatory
factors in HUVECs [6,8,9]. An association has been found between p38
MAPK and NF-κB activation in several cell types, including HeLa cells
[10], and a recent study linked the p38 MAPK/MK2/HSP27 pathway to
NF-κB intranuclear retention, a mechanism for controlling the level
and duration of NF-κB activation [11]. However, the inﬂuence of the
p38 MAPK pathway on TNF-induced NF-κB activation in lung MVECs
has not been determined.
MAPK-activated protein kinase 2 (MK2) is a downstream kinase of
p38 MAPK [12,13]. It is phosphorylated by p38 MAPK and it, in turn,
phosphorylates heat shock protein 27 (HSP27) to induce smoothmuscle
cellmigration [14]. In addition, the p38MAPK/MK2/HSP27 pathway has
been shown to mediate NF-κB activation in HUVECs [11] and
cytoskeletal changes in rat pulmonary endothelial cells [15]. Recently,
HSP27 was found to be required for the IL-1-induced expression of the
pro-inﬂammatory mediators cyclooxygenase-2, IL-6, and IL-8 in HeLa
cells and ﬁbroblasts [16]. However, it is unknown whether MK2 and
HSP27 are involved in regulating the TNF-induced pro-inﬂammatory
response in lung MVECs. Evaluating the role of the p38 MAPK/MK2/
Table 2
Sequences of ICAM-1, IL-8 and GAPDH primers
Primers
ICAM-1 Sense 5′-AGCTTCTCCTGCTCTGCAAC-3′
Antisense 5′-GTCTGCTGGGAATTTTCTGG-3′
IL-8 Sense 5′-CAGGAATTGAATGGGTTTGC-3′
Antisense 5′-AAACCAAGGCACAGTGGAAC-3′
GAPDH Sense 5′-CATGGCCTCCAAGGAGTAAG-3′
Antisense 5′-AGGGGTCTACATGGCAACTG-3′
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MVECs may provide insight into the mechanism(s) by which TNF
contributes to early events in acute lung injury and ARDS. Therefore in
this studywe examined: 1) the relative role of the p38MAPK and ERK 1/
2 pathways in the TNF-induced expression of ICAM-1 and IL-8 inhuman
lung MVECs, 2) whether p38 MAPK regulates the TNF-induced expres-
sion of ICAM-1 and IL-8 at the level of transcriptional control by NF-κB,
and 3) whether MK2 and/or HSP27 is involved in this regulation.
2. Materials and methods
2.1. Materials
Human lung MVECs and cell culture reagents were purchased from Lonza
(Walkersville, MD). TNF and Accutase solution were purchased from Sigma-Aldrich
(St. Louis, MO). SB203580 (p38 MAPK inhibitor) and PD98059 (MAPK kinase inhibitor
that inhibits ERK1/2 activation) were purchased from Calbiochem (San Diego, CA).
Protein assay reagent and ECL immunoblotting substrate were purchased from Pierce
(Rockford, IL). Antibodies against phosphorylated p38 (Thr180/Tyr182, #9211),
phosphorylated ERK1/2 (Thr202/Tyr204, #9102), total MK2 (#3042), phosphorylated
MK2 (Thr-334, #3041), phosphorylated HSP27 (Ser 78, #2405), phosphorylated NF-κB
p65 (Ser536, #3033) and β-actin (#4967) were purchased from Cell Signaling (Danvers,
MA). Total HSP27 antibody (spa-803) was purchased from Stressgen (Ann Arbor, MI).
HSP27 siRNA (sc-29350), scrambled siRNA (sc-37007), transfection reagents (sc-
29528), transfection medium (sc-36868) and ICAM-1 antibody (H108, sc-7891) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Film was bought from
Bioexpress (Kaysville, UT). ON-TARGET plus SMART pool human MK2 siRNA (L-003516-
00-0005), scrambled siRNA (D-001700-01-20), DharmaFECT1 transfection reagent (T-
2001-02) and other transfection-related reagents for MK2 knockdown experiments
were purchased from Dharmacon (Lafayette, CO). Opti-MEM I reduced serum medium
was purchased from Invitrogen (Carlsbad, CA). PE-conjugated anti-human ICAM-1
antibody and PE-conjugatedmouse IgG1 isotype control antibody were purchased from
eBioscience (San Diego, CA). RNeasy micro kit was purchased from QiaGen (Valencia,
CA). IL-8 and MCP-1 ELISA Kits were purchased from R&D (Minneapolis, MN).
2.2. Cell culture and treatment
Human lung MVECs were cultured in complete medium (EGM-2 medium with 5%
fetal bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin) at 37 °C in an
incubator supplied with 5% CO2. Cells from passages 5 to 8 were used for all
experiments. Unless otherwise speciﬁed, cells were at 90% conﬂuence. For certain
experiments, cells were stimulated with TNF (10 ng/ml). MAPK inhibitors (SB203580
and PD98059, various concentrations) were added to culture media 30 min before TNF
stimulation and were present during TNF stimulation.
2.3. Immunoblotting
Immunoblotting was used to detect ICAM-1, phosphorylated p38 and ERK1/2, total
and phosphorylated MK2 (Thr-334), total and phosphorylated HSP27 (Ser78 and
Ser82), and phosphorylated NF-κB p65, with β-actin as a control. After treatment,
human lung MVECs were lysed with lysis buffer (PBS containing a protease inhibitor
cocktail and 1% Triton X100, pH 7.4). Cell samples were separated on 4–20% SDS-
polyacrylamide gels (Bio-Rad, Hercules, CA), then transferred to nitrocellulose mem-Table 1
Sequences of MK2 and HSP27 siRNA and corresponding scrambled siRNA
MK2 HSP27
Knock-down
siRNA pool
Sense 5′-
CGAAUGGGCCAGUAUGAAUUU-3′
Sense 5′-
GAGUGGUCGCAGUGGUUAGtt-3′
Antisense 5′-
PAUUCAUACUGGCCCAUUCGUU-3′
Antisense 5′-
CUAACCACUGCGACCACUCtt-3′
Sense 5′-
GUUAUACACCGUACUAUGUUU-3′
Sense 5′-
GACGAGCUGACGGUCAAGAtt-3′
Antisense 5′-
PACAUAGUACGGUGUAUAACUU-3′
Antisense 5′-
UCUUGACCGUCAGCUCGUCtt-3′
Sense 5′-
GGCAUCAACGGCAAAGUUUUU-3′
Sense 5′-
CCACGCAGUCCAACGAGAUtt-3′
Antisense 5′-
PAAACUUUGCCGUUGAUGCCUU-3′
Antisense 5′-
AUCUCGUUGGACUGCGUGGtt-3′
Sense 5′-
CCACCAGCCACAACUCUUUUU-3′
Antisense 5′-
PAAAGAGUUGUGGCUGGUGGUU-3′
Scrambled
siRNA
Sense 5′-
UAGCGACUAAACACAUCAAUU-3′
Sense 5′-
UUCUCCGAACGUGUCACGUTT-3′
Antisense 5′-
PUUGAUGUGUUUAGUCGCUAUU-3′
Antisense 5′-
ACGUGACACGUUCGGAGAATT-3′branes. Membranes were rinsed in PBS and blocked for 1 h at room temperature with
5% dry milk in TPBS (PBS containing 0.1% Tween 20), then incubated with the
appropriate primary antibodies (ICAM-1 antibody was diluted 1:200, phosphorylated
ERK1/2 antibody 1:500, and all others 1:1000) overnight at 4 °C. After washing 4×5min
with TPBS, membranes were incubated with Horseradish peroxidase (HRP)-linked
secondary antibodies (1:5000 dilution with TPBS containing 5% dry milk) at room
temperature for 1 h. After washing 4×5 min with TPBS, target bands were developed
using ECL and exposed on ﬁlm. Band density was measured using NIH software ImageJ.
2.4. Gene knockdown
SiRNA transfection was performed to silence MK2 and HSP27. Human lung MVECs
were cultured in antibiotic-free growth medium in 12-well plates (for immunoblotting)
or 6-well plates (for PCR) until 60% conﬂuent. For HSP27 siRNA transfection, cells were
incubated with a mixture of HSP27 siRNA (60 nM) and transfection reagent (sc-29528,
6 μl/ml transfection medium) in antibiotic- and serum-free medium for 6 h, which we
found to be the optimal time. The 70–80% of cells still alive after transfection were
allowed to recover in growthmedium for 48 h, then stimulatedwith TNF. Controls were
treated with scrambled siRNA (sc-37007) and transfection reagent (sc-29528). For MK2
siRNA transfection, a transfection mixture of MK2 siRNA (30 nM) and DharmaFECT1
transfection reagent (0.5 μl/ml) was made in Opti-MEM I reduced serum medium. Cells
were incubated with the transfection mixture in complete medium for 48 h, which we
found to be the optimal transfection time. The more than 95% of cells still alive after
transfection were incubated in growth medium for 24 h, then stimulated with TNF.
Controls were treated with scrambled siRNA (D-001700-01-20) and DharmaFECT1
transfection reagent (T-2001-02). The sense and antisense siRNA oligonucleotides used
to generate siRNA are detailed in Table 1.
2.5. Flow cytometry
Flow cytometry was used to detect cell-surface expression of ICAM-1. Brieﬂy, cells
were detached using ACCUTASE (500 U/ml) and collected. After washing with PBS
twice, cells were incubatedwith 20 μl PE-conjugated anti-human ICAM-1 antibodies for
30 min at 4 °C. PE-conjugated mouse IgG1 isotype antibody was used as the negative
control. Cells were then washed with PBS twice, ﬁxed with 2% paraformaldehyde and
stored in the dark at 4 °C. Samples were read on a ﬂow cytometer (FACScan, Becton
Dickinson, TX). MFI values were corrected for isotype-matched controls.
2.6. RNA isolation and real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
analysis
RNAwas extracted using TRIZOL reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer's protocol. Five μg total RNA was treated with RNase-free DNase and
puriﬁedwith an RNeasymicro kit. Quantitative PCR conﬁrmed that the RNA samplewas
not contaminated with DNA. RNA (1 µg) was then reverse transcribed using oligo(dT)
primers and the SuperScript ﬁrst strand synthesis kit (Invitrogen) according to the
manufacturer's protocol.WeusedGAPDHas the normalization control. The sequences of
the primers are detailed in Table 2. Gene expressionwas assessed by real-time PCRusing
SYBR GreenMaster Mix (Eurogentec, San Diego, CA). The real-time PCR thermal proﬁles
are as follows: 30 to 35 ampliﬁcation cycles of 10 s at 95 °C,15 s at 66 °C and 20 s at 72 °C,
followed by melting curve analysis. The Rotor-Gene 3000 (Corbett Research, Sydney,
Australia) Real-Time DNA Detection System was used for these reactions. Speciﬁcity of
amplicons was veriﬁed by melting curve analysis when using SYBR Green as a detector.
Negative andpositive controls and the standard curvewere included in the experiments.
2.7. ELISA
ELISA kits (R&D, Minneapolis, MN) were utilized to analyze the release of IL-8 and
MCP-1. Recombinant proteins were used to construct standard curves. Absorbance of
standards and samples was determined spectrophotometrically at 450 nm using a
microplate reader.
2.8. Immunoﬂuorescent staining
Immunoﬂuorescent staining was performed to examine NF-κB intranuclear
translocation in human lung MVECs following TNF stimulation. Brieﬂy, cells were
cultured in 8-well chamber slides to 30–40% conﬂuence. The P38 inhibitor SB203580
(10 μM) was added to cells 30 min prior to TNF stimulation. Cells were then stimulated
1625X. Su et al. / Biochimica et Biophysica Acta 1783 (2008) 1623–1631with TNF for 1 or 2 h. After washing with cold PBS, cells were incubated with a mixture
of 30% methanol and 70% acetone at room temperature for 5 min and then air dried.
After ﬁxing in PBS-buffered 3.5% paraformaldehyde at room temperature for 10min and
washing with PBS, cells were blocked with 10% donkey serum for 30 min. Then cells
were incubated for 2 h with a rabbit polyclonal antibody against NF-κB p65. Control
cells were incubated with non-immune rabbit IgG. After washing with PBS, cells were
incubated with Cy3-conjugated donkey anti-rabbit IgG for 1 h. Nuclei were counter-
stained with bis-benzimide and cell membranes with wheat germ agglutinin tagged
with Alexa 488 (Molecular Probes, Eugene OR). Cells were then washed with PBS and
mounted with aqueous mounting media. Photography was performed with a Leica
DMRX microscope (Wetzlar, Germany).
2.9. NF-κB p65 DNA-binding assay
This assay is based on the speciﬁc binding of activated NF-κB p65 to a consensus
oligonucleotide and provides quantitative results [17]. Nuclear extracts were preparedFig. 1. p38 MAPK, not ERK1/2, mediates TNF-induced ICAM-1 and IL-8 expression in
phosphorylation of p38 MAPK and ERK1/2 in human lung MVECs and gradually increased c
inﬂuence total cellular ICAM-1 levels following TNF stimulation (B), inhibition of p38MAPKw
in a dose-dependent manner (D). Inhibition of p38MAPKwith SB203580 (10 µM) also reduce
ERK1/2 had no effect on IL-8 release (F), inhibition of p38 MAPK with SB203580 (10 μM) red
ELISA data are expressed as mean±SEM. n=4, ⁎Pb0.05 vs. untreated controls, #Pb0.05 vs. TN
vs. TNF alone. P-p38 = phosphorylated p38, P-ERK1/2 = phosphorylated ERK1/2, SB = SB203using anextractionkit (ActiveMotif, Carlsbad, CA).NF-κB activitywas assayedusing anNF-
κB p65 DNA-binding assay kit (Active Motif), following the manufacturer's instructions.
2.10. Statistics
Statistical analysis was performed by ANOVAwith a post hoc Bonferroni/Dunn test.
Statistical signiﬁcance was accepted within a 95% conﬁdence limit.
3. Results
3.1. P38 MAPK, not ERK1/2, regulates TNF-induced ICAM-1 and IL-8
expression in human lung MVECs
Both p38 MAPK and ERK1/2 have been reported to play a role in
the inﬂammatory response to TNF in HUVECs [9,18]. We evaluated thehuman lung MVECs. Representative immunoblots show that TNF rapidly induced
ellular ICAM-1 levels (A). While inhibition of ERK1/2 activation with PD98059 did not
ith SB203580 reduced total cellular ICAM-1 levels at all time points we observed (C) and
d cell-surface ICAM-1 levels on cells stimulatedwith TNF for 24 h (E).While inhibition of
uced IL-8 release at all time points we observed (G). Band density, ﬂow cytometry and
F alone (in D and E) or TNF alone at the corresponding time point (in G), †non-signiﬁcant
580.
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ICAM-1 and IL-8 in human lung MVECs. Levels of phosphorylated p38
and ERK1/2 increased 10 min after TNF stimulation and then declined
(Fig. 1A). Total cellular ICAM-1 levels increased markedly 4 h after TNF
stimulation and continued to increase to their highest observed levels
after 24 h (Fig. 1A). Cell-surface levels of ICAM-1 were signiﬁcantly
elevated 24 h after TNF stimulation (Fig. 1E). TNF also stimulated the
release of IL-8 (Fig. 1F). IL-8 release followed the same temporal
pattern as ICAM-1 expression, increasing after 4 h and reaching its
highest observed level by 24 h (Fig. 1G). After TNF stimulation for 24 h,
IL-8 levels increased by 12 fold (Pb0.05). Inhibiting ERK1/2 with the
speciﬁc inhibitor PD98059 (12.5–50 μM) had no inﬂuence on total
cellular ICAM-1 levels (Fig. 1B) or on IL-8 release (Fig. 1F). By contrast,
inhibiting p38 MAPK with the speciﬁc inhibitor SB203580 reduced
total cellular levels of ICAM-1 at all time points (Fig. 1C) when
compared to cells treated with TNF alone (a representative immuno-Fig. 2. Inhibition of p38 MAPK has no inﬂuence on NF-κB activation or ICAM-1 and IL-8 mRN
SB203580 did not inﬂuence NF-κB p65 phosphorylation (A), intranuclear translocation (B) or
of SB203580 in (B) and (C) is 10 µM.) ICAM-1 and IL-8 mRNA levels (normalized with GAPDH
Inhibition of p38MAPK did not inﬂuence ICAM-1 or IL-8 mRNA levels (D, E). Band density, NF
corresponding control, †non-signiﬁcant vs. TNF alone at corresponding time point. P-NF-κBblot is shown in Fig. 1A). Further, the effect of the p38 MAPK inhibitor
was dose-dependent (Fig. 1D). Inhibiting p38 MAPK also resulted in
reduced cell-surface ICAM-1 levels (Fig. 1E). Moreover, inhibiting
p38 MAPK reduced IL-8 release 4 to 24 h following TNF stimulation
(Fig. 1G). These results demonstrate that in human lung MVECs, the
p38 MAPK pathway and not the ERK1/2 pathway regulates the TNF-
induced expression of ICAM-1 and IL-8.
3.2. P38 MAPK regulates TNF-induced ICAM-1 and IL-8 expression in
human lung MVECs through a post-transcriptional mechanism
NF-κB is the primary transcription factor for the expression of
ICAM-1 and IL-8. To determinewhether p38mediates the TNF-induced
expression of ICAM-1 and IL-8 by inﬂuencing NF-κB activation, we
examined the effect of SB203580 on NF-κB p65 phosphorylation,
intranuclear translocation and DNA-binding activity. Inhibiting p38A levels in human lung MVECs following TNF stimulation. Inhibition of p38 MAPK with
DNA-binding activity (C) in human lungMVECs stimulatedwith TNF. (The concentration
) increased 1 h after TNF stimulation, peaked at 4 h and returned to baseline after 8 h.
-κB DNA-binding activity andmRNA data are expressed asmean±SEM, n=3, ⁎Pb0.05 vs.
= phosphorylated NF-κB, SB = SB203580.
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(Fig. 2A), intranuclear translocation (Fig. 2B) or DNA-binding activity
(Fig. 2C) in human lung MVECs stimulated with TNF.
ICAM-1 and IL-8 mRNA levels increased 1 h after TNF stimulation,
reachedapeakafter 4h and returned to baseline after 8h (Fig. 2DandE).
Inhibiting p38 MAPK with SB203580 did not reduce ICAM-1 and IL-8
mRNA levels, nor did it change the temporal pattern of ICAM-1 and IL-8
mRNAexpression. Therefore thep38MAPKpathwayappears to regulate
the expression of ICAM-1 and IL-8 in human lung MVECs at a post-
transcriptional level.
3.3. MK2 mediates the effect of p38 MAPK on TNF-induced ICAM-1 and
IL-8 expression
Studies of other endothelial cells have shown that MK2 is a
downstream factor in the p38 MAPK pathway and that inhibition ofFig. 3. MK2 is involved in regulating the TNF-induced expression of ICAM-1 and IL-8 in hum
phosphorylation is stimulated by TNF but inhibited by the p38MAPK inhibitor SB203580 (A).M
TNF stimulation.MK2 silencing attenuated the TNF-induced increase in total cellular ICAM-1 l
release following TNF stimulation (F). Band density, ﬂowcytometry and ELISAdata are express
controls (in B, C, D, E, F), †Pb0.05 vs. TNF alone, #Pb0.05 vs. scrambled siRNA plus TNF. NS =p38 MAPK reduces the phosphorylation of MK2 in response to pro-
inﬂammatory stimuli. To determine the role of MK2 in the p38 MAPK
pathway in human lung MVECs, we applied SB203580 (5 or 10 μM)
30 min before TNF stimulation and examined MK2 phosphorylation.
As shown in Fig. 3A, phosphorylated MK2was detected 10 and 30 min
after TNF stimulation, but was reduced when p38MAPKwas inhibited
with SB203580. Therefore MK2 is downstream of p38MAPK in human
lung MVECs.
We took the knockdown approach to determine the role of MK2 in
the regulation of TNF-induced ICAM-1 and IL-8 expression by p38
MAPK. As shown in Fig. 3B, MK2 levels in cells transfected with MK2
siRNA (30 nM) were 10% of controls (cells transfected with scrambled
siRNA). Similarly,MK2 silencing reduced levels of phosphorylatedMK2
to approximately 10% of controls (Fig. 3C). We determined the effect of
MK2 silencing on TNF-induced ICAM-1 and IL-8 expression. As shown
in Fig. 3D and E, both total cellular and cell-surface ICAM-1 levels werean lung MVECs. Representative immunoblots with band density data show that MK2
K2 silencingmarkedly reduced levels ofMK2 (B) and phosphorylatedMK2 (C) following
evels (D) and cell-surface ICAM-1 levels (E). MK2 silencing also signiﬁcantly reduced IL-8
ed asmean±SEM. n=4, ⁎Pb0.05 vs. untreated controls (in A) or scrambled siRNA-treated
non-signiﬁcant, P-MK2 = phosphorylated MK2, SsiRNA = scrambled siRNA.
Fig. 4.MK2 silencing has no inﬂuence on NF-κB activation or ICAM-1 and IL-8 mRNA levels in human lungMVECs following TNF stimulation. MK2 silencing (30 nM) did not inﬂuence
NF-κB p65 phosphorylation (A), NF-κB DNA-binding activity (B) or ICAM-1 and IL-8 mRNA levels (normalized with GAPDH) (C) in human lung MVECs stimulated with TNF. Band
density, NF-κB DNA-binding activity and mRNA data are expressed as mean±SEM. n=3, ⁎Pb0.05 vs. controls treated with scrambled siRNA alone, †non-signiﬁcant vs. scrambled
siRNA plus TNF at corresponding time point. P-NF-κB = phosphorylated NF-κB, SsiRNA = scrambled siRNA.
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MK2 silencing reduced IL-8 release to 48% of controls treated with
scrambled siRNA and TNF (Fig. 3F). These results indicate that MK2 is
involved in regulating the TNF-induced expression of ICAM-1 and IL-8
in human lung MVECs by the p38 MAPK pathway.
To determine whether MK2 regulates ICAM-1 and IL-8 gene
expression, we examined the effect of MK2 silencing on TNF-induced
NF-κB activation and ICAM-1 and IL-8 mRNA expression. Consistent
with our results on p38 MAPK inhibition, MK2 silencing had no effect
on NF-κB p65 phosphorylation (Fig. 4A) or NF-κB DNA-binding
activity (Fig. 4B). Similarly, MK2 silencing had no inﬂuence on
ICAM-1 and IL-8 mRNA levels or on the temporal pattern of ICAM-1
and IL-8 mRNA expression (Fig. 4C). These results further indicate that
the p38 MAPK/MK2 pathway regulates TNF-induced ICAM-1 and IL-8
expression in human lung MVECs at a post-transcriptional level.
The p38MAPK/MK2 pathway has been shown to play an important
role in the post-transcriptional regulation of LPS-induced TNF ex-
pression. This regulation is dependent on the presence of adenine/
uridine-rich elements (AREs) in the 3′ untranslated region (UTR) of
TNFmRNA [19,20]. A typical ARE sequence is AUUUA. According to the
Nucleotide database, ICAM-1 and IL-8 have two and eight copies,
respectively, of the AUUUA motif at the 3′UTR of their mRNA
sequences. By contrast, MCP-1 does not have an ARE in its mRNA. To
determine whether p38 MAPK/MK2 signaling is ARE-dependent in
human lung MVECs, we examined the inﬂuence of p38 MAPK
inhibition and MK2 silencing on MCP-1 expression. TNF stimulation
signiﬁcantly increased MCP-1 mRNA levels in cells (peak MCP-1
mRNA/GAPDH mRNA ratio compared to untreated controls: 41.3±3.5
in TNF 4 h) andMCP-1 protein levels in culturemedium (5.80±0.38 ng/
ml vs. 0.18±0.33 ng/ml in untreated controls, Pb0.01). However,neither p38MAPK inhibition norMK2 silencing had any effect on TNF-
induced MCP-1 mRNA expression (peak MCP-1 mRNA/GAPDH mRNA
ratio compared to untreated controls: 37.1±4.7 and 39.3±3.6 in SB+
TNF and MK2 siRNA+TNF, respectively, vs. 41.3±3.5 and 43.6±3.9 in
TNF alone and scrambled siRNA+TNF, respectively) or MCP-1 protein
production (6.26±0.73 ng/ml in cells pretreated with SB203580 and
5.12±0.57 ng/ml in cells pretreated with MK2 siRNA, both PN0.05).
These results suggest that the post-transcriptional regulation of TNF-
induced ICAM-1 and IL-8 expression by the p38 MAPK/MK2 pathway
may be at the level of ARE-dependent translation.
3.4. HSP27 is not involved in the regulation of TNF-induced ICAM-1 and
IL-8 expression by the p38 MAPK/MK2 pathway
Another downstream component of the p38 MAPK signaling
pathway is HSP27 [21,22]. HSP27 has been found to play a role in the
post-transcriptional expression of pro-inﬂammatory factors in HeLa
cells and ﬁbroblasts [16] and to regulate the release of pro-inﬂam-
matory mediators in keratinocytes by modulating NF-κB activation
[11]. To determine whether HSP27 is involved in the p38 MAPK/MK2-
mediated post-transcriptional regulation of TNF-stimulated ICAM-1
and IL-8 expression in human lung MVECs, we ﬁrst determined the
role of the p38 MAPK/MK2 pathway in HSP27 phosphorylation. TNF
stimulation increased levels of phosphorylated HSP27, but this effect
was absent in cells pretreated with the p38 MAPK inhibitor SB203580
(Fig. 5A). MK2 silencing reduced HSP27 phosphorylation by 87% after
10 min of TNF stimulation and approximately 50% after 30 min of TNF
stimulation (Fig. 5B). Therefore the TNF-induced phosphorylation of
HSP27 in human lung MVECs is primarily mediated by the p38 MAPK/
MK2 pathway.
Fig. 5. TNF induces HSP27 phosphorylation in human lung MVECs through the p38
MAPK/MK2 pathway. Representative immunoblots with band density data show that
TNF-induced HSP27 phosphorylation was abolished by p38 MAPK inhibition (A) and
markedly attenuated by MK2 silencing (B). Band density data are expressed as mean±
SEM. n=3, ⁎Pb0.05 vs. untreated controls (in A) or scrambled siRNA-treated controls
(in B), #Pb0.05 vs. TNF (in A) or scrambled siRNA plus TNF (in B) at corresponding time
point. P-HSP27 = phosphorylated HSP27, SsiRNA = scrambled siRNA.
1629X. Su et al. / Biochimica et Biophysica Acta 1783 (2008) 1623–1631Next we examined the effect of HSP27 silencing on TNF-induced
ICAM-1 and IL-8 expression. We transfected human lung MVECs with
HSP27 siRNA for 6 h, allowed them to recover for 48 h, and then
stimulated them with TNF. Immunoblotting conﬁrmed that HSP27
siRNA (60 nM) effectively reduced levels of both HSP27 (Fig. 6A) and
phosphorylatedHSP27 (Fig. 6B). However, neither total cellular nor cell-
surface ICAM-1 levels were affected by HSP27 silencing (Fig. 6C and D).
Similarly, HSP27 silencingdidnot affect the amountof IL-8 released into
the culture medium in response to TNF (Fig. 6E). These results show
that, although HSP27 phosphorylation is mediated by the p38 MAPK/
MK2pathway, reducing total andphosphorylatedHSP27 levels doesnot
inﬂuence ICAM-1 and IL-8 expression in human lung MVECs.
4. Discussion
Multiple MAPK pathways regulate the cellular inﬂammatory
response. The ERK1/2 and p38 MAPK pathways have been shown to
be involved in regulating the expression of ICAM-1 and IL-8 in several
cell types [9,18,23]. In HUVECs, the p38 MAPK pathway is critically
important in regulating IL-8 expression [6], but both p38 MAPK and
ERK1/2 appear to be minimally involved in regulating ICAM-1
expression [6,8]. In the present study on human lung MVECs, we
found that the pro-inﬂammatory stimulus TNF induced rapid
phosphorylation of both ERK1/2 and p38 MAPK and increased proteinlevels of ICAM-1 and IL-8 up to 24 h afterwards. Treatment with the
ERK1/2 inhibitor PD98059 at several concentrations did not affect
ICAM-1 and IL-8 levels following TNF stimulation. By contrast,
inhibition of p38 MAPK with SB203580 signiﬁcantly reduced TNF-
induced IL-8 release and both total cellular and cell-surface ICAM-1
expression. Thus p38 MAPK, but not ERK1/2, regulates TNF-induced
expression of ICAM-1 and IL-8 in human lung MVECs.
A previous study has examined the inﬂuence of p38 MAPK
inhibition on TNF-induced ICAM-1 expression in human lung MVECs
[24]. That study found reduced cell-surface distribution of ICAM-1 6 h
after TNF stimulation in cells treated with SB203580, so the authors
concluded that the p38 MAPK pathway regulates ICAM-1 redistribu-
tion in response to TNF stimulation. In our study, we analyzed both
cell-surface and total cellular ICAM-1 levels following 24-h TNF
stimulation and found that inhibition of p38 MAPK reduces both
total cellular and cell-surface ICAM-1 levels. Moreover, we found that
the reduction in cell-surface levels of ICAM-1 is proportional to the
decrease in total cellular ICAM-1 levels. Thereforep38MAPK inhibition
seems to inﬂuence cell-surface ICAM-1 distribution primarily by
down-regulating ICAM-1 expression.
Although the p38 MAPK pathway plays a critical role in regulating
the inﬂammatory response to TNF in a variety of cell types, the
mechanism by which it regulates that response appears to differ in
endothelial cells from different vascular beds. The p38MAPK pathway
was found to be involved in regulating the TNF-induced expression of
IL-8 but not ICAM-1 in HUVECs [6,8], whereas we found that the p38
MAPK pathway is involved in regulating the TNF-induced expression
of both IL-8 and ICAM-1 in human lung MVECs. Apparently,
endothelial cells from different microenvironments use different
signaling networks.
NF-κB is the primary transcription factor involved in regulating the
inﬂammatory response toTNF in endothelial cells [8,11]. Indeed, NF-κB
inhibition drastically reduced ICAM-1 expression in HUVECs [8]. To
evaluate the role of NF-κB in the p38 MAPK-mediated expression of
ICAM-1 and IL-8 in human lungMVECs, we examined the effect of p38
inhibition on NF-κB p65 phosphorylation, intranuclear translocation
and DNA-binding activity. Surprisingly, inhibition of p38 MAPK with
SB203580 had no inﬂuence on any of these indices of NF-κB activation,
indicating that the p38 MAPK pathway regulates TNF-induced
expression of ICAM-1 and IL-8 in human lung MVECs independent of
NF-κB. Consistent with these ﬁndings, inhibition of p38 MAPK did not
inﬂuence the TNF-stimulated increase in ICAM-1 and IL-8mRNA levels
nor change the kinetics of ICAM-1 and IL-8mRNAexpression. Although
inhibition of p38 MAPK did not affect ICAM-1 and IL-8 mRNA
expression, it signiﬁcantly reduced the subsequent production and
accumulation/release of ICAM-1 and IL-8 proteins up to 24 h after TNF
stimulation. Thus the p38 MAPK pathway appears to regulate ICAM-1
and IL-8 expression in human lung MVECs at a post-transcriptional
level. This ﬁnding is consistent with an earlier report that inhibition of
p38MAPK in rheumatoid synovial ﬁbroblasts reduces TNF-induced IL-
8 peptide expression without affecting IL-8 mRNA levels [25].
MK2 and HSP27 are downstream factors in the p38 MAPK
pathway. The p38 MAPK/MK2/HSP27 pathway has been found to
mediate TNF-induced cytoskeletal changes in rat pulmonary endothe-
lial cells [15]. In addition, HSP27 was recently found to play a critical
role in the IL-1-induced expression of pro-inﬂammatory mediators
such as cyclooxygenase-2, IL-6, and IL-8 in HeLa cells and ﬁbroblasts
[16]. Our study showed that TNF induced the phosphorylation of both
MK2 and HSP27 in human lung MVECs in a p38 MAPK-dependent
fashion, suggesting that MK2 and HSP27 play a role in regulating the
pro-inﬂammatory response to TNF in lung MVECs by p38 MAPK. MK2
silencing did indeed signiﬁcantly reduce levels of both IL-8 and ICAM-
1 following TNF stimulation, but HSP27 silencing had no effect onTNF-
stimulated IL-8 and ICAM-1 expression. Therefore, the TNF-induced
expression of ICAM-1 and IL-8 in human lungMVECs seems to involve
MK2 but is independent of HSP27.
Fig. 6. HSP27 silencing fails to inﬂuence TNF-induced ICAM-1 and IL-8 expression in human lung MVECs. HSP27 silencing markedly reduced levels of cellular HSP27 (A). TNF-
stimulated levels of phosphorylatedHSP27were reduced in cells subjected toHSP27 silencing (B). HSP27 silencing failed to inﬂuence either total (C) or cell-surface (D) levels of ICAM-1.
HSP27 silencing also failed to inﬂuence IL-8 expression (E). Band density, ﬂow cytometry and ELISA data are expressed as mean±SEM. n=4, ⁎Pb0.05 vs. controls (untreated or treated
with scrambled siRNA alone), #Pb0.05 vs. scrambled siRNA plus TNFat corresponding time point, †non-signiﬁcant vs. scrambled siRNA plus TNF at corresponding time point. P-HSP27
= phosphorylated HSP27, SsiRNA = scrambled siRNA.
1630 X. Su et al. / Biochimica et Biophysica Acta 1783 (2008) 1623–1631We demonstrated that MK2 is involved in regulating the TNF-
induced expression of ICAM-1 and IL-8 by p38 MAPK in human lung
MVECs at a post-transcriptional level. MK2 has previously been shown
to regulate ARE-dependent TNF translationwithout inﬂuencing either
mRNA levels or mRNA stability [19,20]. We compared the inﬂuence of
p38 MAPK inhibition and MK2 silencing on the expression of ICAM-1
and IL-8, which have the AUUUA motif at the 3′UTR of their mRNA,
and on the expression of MCP-1, which does not have an ARE in its
mRNA. Since neither p38 MAPK inhibition nor MK2 silencing affected
levels of MCP-1, it appears that the post-transcriptional regulation of
TNF-induced ICAM-1 and IL-8 expression by the p38 MAPK/MK2
pathway is at the level of ARE-dependent translation. Further, our PCRresults demonstrated no decrease in mRNA levels. Thus MK2 may
regulate the expression of ICAM-1 and IL-8 by inﬂuencing the
translational efﬁciency of ICAM-1 and IL-8 mRNA.
In this study, we examined the role of ERK1/2, p38 MAPK, MK2, and
HSP27 in regulating the TNF-induced expression of ICAM-1 and IL-8 in
human lung MVECs. Our results demonstrate for the ﬁrst time that the
p38 MAPK/MK2 pathway plays a critical role in regulating both ICAM-1
and IL-8 expression in human lungMVECs, and that this regulation is at
the post-transcriptional level anddoesnot involveHSP27. Since both IL-8
and ICAM-1 are necessary for neutrophil accumulation and inﬁltration in
the lung [2], ourﬁndings indicate that thep38MAPKpathwaymayplaya
critical role in the pulmonary inﬂammatory response. One limitation of
1631X. Su et al. / Biochimica et Biophysica Acta 1783 (2008) 1623–1631our study is that it was performed on cultured human lung MVECs that
maybehavedifferently than cells invivo. Further invivo study is required
to determine the role of the p38 MAPK/MK2 pathway in the pulmonary
inﬂammatory response and acute lung injury.
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